PL1987010T3 - Pochodne N-heteroarylokarboksyamidów tricyklicznych zawierających ugrupowanie benzimidazolu, ich wytwarzanie i ich zastosowanie w lecznictwie - Google Patents

Pochodne N-heteroarylokarboksyamidów tricyklicznych zawierających ugrupowanie benzimidazolu, ich wytwarzanie i ich zastosowanie w lecznictwie

Info

Publication number: PL1987010T3
Authority: PL; Poland
Prior art keywords: tricyclic; heteroaryl; therapeutic use; derivatives containing; preparing same
Prior art date: 2006-02-03

Application number

PL07730900T

Other languages

English (en)

Inventor

Laurent Dubois

Yannick Evanno

Luc Even

Catherine Gille

André Malanda

David Machnik

Nathalie Rakotoarisoa

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-02-03

Filing date

2007-02-01

Publication date

2010-09-30

2007-02-01 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2010-09-30 Publication of PL1987010T3 publication Critical patent/PL1987010T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Virology (AREA)
Hematology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Gynecology & Obstetrics (AREA)
Psychiatry (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Pregnancy & Childbirth (AREA)
Communicable Diseases (AREA)
Biotechnology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL07730900T 2006-02-03 2007-02-01 Pochodne N-heteroarylokarboksyamidów tricyklicznych zawierających ugrupowanie benzimidazolu, ich wytwarzanie i ich zastosowanie w lecznictwie PL1987010T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0601007A FR2897061B1 (fr)	2006-02-03	2006-02-03	Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique.
EP07730900A EP1987010B1 (fr)	2006-02-03	2007-02-01	Dérivés de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur préparation et leur application en thérapeutique
PCT/FR2007/000183 WO2007088277A1 (fr)	2006-02-03	2007-02-01	Dérivés de ν-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur préparation et leur application en thérapeutique

Publications (1)

Publication Number	Publication Date
PL1987010T3 true PL1987010T3 (pl)	2010-09-30

Family

ID=36954977

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07730900T PL1987010T3 (pl)	2006-02-03	2007-02-01	Pochodne N-heteroarylokarboksyamidów tricyklicznych zawierających ugrupowanie benzimidazolu, ich wytwarzanie i ich zastosowanie w lecznictwie

Country Status (33)

Country	Link
US (2)	US8143248B2 (pl)
EP (1)	EP1987010B1 (pl)
JP (1)	JP5136938B2 (pl)
KR (1)	KR20080090495A (pl)
CN (1)	CN101379041B (pl)
AR (1)	AR059279A1 (pl)
AT (1)	ATE463484T1 (pl)
AU (1)	AU2007211399B2 (pl)
BR (1)	BRPI0710480A2 (pl)
CA (1)	CA2637333C (pl)
CY (1)	CY1110168T1 (pl)
DE (1)	DE602007005779D1 (pl)
DK (1)	DK1987010T3 (pl)
DO (1)	DOP2007000022A (pl)
EA (1)	EA014450B1 (pl)
ES (1)	ES2344087T3 (pl)
FR (1)	FR2897061B1 (pl)
HK (1)	HK1129670A1 (pl)
HR (1)	HRP20100327T1 (pl)
IL (1)	IL192648A (pl)
JO (1)	JO2602B1 (pl)
MA (1)	MA30229B1 (pl)
NO (1)	NO20083520L (pl)
NZ (1)	NZ569669A (pl)
PE (1)	PE20071325A1 (pl)
PL (1)	PL1987010T3 (pl)
PT (1)	PT1987010E (pl)
RS (1)	RS51366B (pl)
SI (1)	SI1987010T1 (pl)
TW (1)	TWI401256B (pl)
UY (1)	UY30130A1 (pl)
WO (1)	WO2007088277A1 (pl)
ZA (1)	ZA200806139B (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2888848B1 (fr) *	2005-07-22	2007-09-28	Sanofi Aventis Sa	Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2911604B1 (fr) *	2007-01-19	2009-04-17	Sanofi Aventis Sa	Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2911605B1 (fr) *	2007-01-19	2009-04-17	Sanofi Aventis Sa	Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique
FR2919610B1 (fr) *	2007-08-02	2009-10-16	Sanofi Aventis Sa	Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique
FR2926556B1 (fr) *	2008-01-22	2010-02-19	Sanofi Aventis	Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
FR2926554B1 (fr)	2008-01-22	2010-03-12	Sanofi Aventis	Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
FR2926555B1 (fr) *	2008-01-22	2010-02-19	Sanofi Aventis	Derives bicycliques de carboxamides azabicycliques, leur preparation et leur application en therapeutique
FR2926553B1 (fr) *	2008-01-23	2010-02-19	Sanofi Aventis	Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique
WO2009108551A2 (en) *	2008-02-25	2009-09-03	H. Lundbeck A/S	Heteroaryl amide analogues
WO2010005528A2 (en) *	2008-06-30	2010-01-14	Ironwood Pharmaceuticals Incorporated	Pyrrolopyridine carboxylic acid derivatives
WO2010051561A1 (en) *	2008-11-03	2010-05-06	Chemocentryx, Inc.	Compounds for the treatment of osteoporosis and cancers
RU2011137419A (ru)	2009-02-11	2013-03-20	Суновион Фармасьютикалз Инк.	Обратные агонисты и антагонисты гистамина н3 и способы их применения
AU2010292285A1 (en) *	2009-09-11	2012-03-15	Sunovion Pharmaceuticals Inc.	Histamine H3 inverse agonists and antagonists and methods of use thereof
JP5673676B2 (ja) *	2010-04-27	2015-02-18	アステラス製薬株式会社	イミダゾ［１，２−ａ］ピリジン誘導体
SI2825541T1 (sl) *	2012-03-16	2016-10-28	Vitae Pharmaceuticals, Inc.	Modulatorji jetrnega receptorja X
BR112014022780A8 (pt)	2012-03-16	2021-06-15	Vitae Pharmaceuticals Inc	composto modulador de receptor de fígado x, composição farmacêutica que o compreende e seu uso
SG11201408397SA (en)	2012-06-18	2015-01-29	Dart Neuroscience Cayman Ltd	Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds
CA2957046C (en)	2014-08-04	2022-11-15	Nuevolution A/S	Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
JP6862368B2 (ja)	2015-06-25	2021-04-21	プロメガコーポレイションＰｒｏｍｅｇａＣｏｒｐｏｒａｔｉｏｎ	チエノピロール化合物、及びそのＯｐｌｏｐｈｏｒｕｓ由来ルシフェラーゼの阻害剤としての使用
AU2017336074A1 (en) *	2016-09-30	2019-03-28	Epizyme, Inc.	Substituted fused bi- or tri- heterocyclic compounds as ehmt2 inhibitors
US10815247B2 (en)	2016-12-28	2020-10-27	Promega Corporation	Functionalized NANOLUC inhibitors
CA3060416A1 (en)	2017-04-21	2018-10-25	Epizyme, Inc.	Combination therapies with ehmt2 inhibitors
CN109761974B (zh) *	2019-01-21	2021-05-14	河南大学	1,2,3,4-四氢-9H-吡啶并[3,4-b]吲哚类TRPV1拮抗剂及其应用
MX2022007265A (es)	2019-12-20	2022-09-09	Nuevolution As	Compuestos activos frente a receptores nucleares.
AU2021249530A1 (en)	2020-03-31	2022-12-01	Nuevolution A/S	Compounds active towards nuclear receptors
US11780843B2 (en)	2020-03-31	2023-10-10	Nuevolution A/S	Compounds active towards nuclear receptors
CN114276354B (zh) *	2022-01-07	2023-06-02	中山大学	1-氨基苯并[4,5]咪唑并[1,2-a]吡嗪-3-甲酰胺类化合物及其制备和应用
CN114539265B (zh) *	2022-03-02	2023-07-21	中山大学	靶向a2a的苯并咪唑并吡嗪-3-甲酰胺及其肿瘤免疫功能

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE455104T1 (de) *	2001-11-01	2010-01-15	Icagen Inc	Pyrazolamide zur anwendung in der behandlung von schmerz
EP1535922A4 (en) *	2002-07-11	2006-10-04	Takeda Pharmaceutical	PYRROLOPYRIDINE DERIVATIVE AND ITS USE
ATE551324T1 (de) *	2003-02-03	2012-04-15	Janssen Pharmaceutica Nv	Chinolin-amid-derivate als modulatoren von vanilloid-vr1-rezeptoren
GB0322016D0 (en) *	2003-09-19	2003-10-22	Merck Sharp & Dohme	New compounds
US7544803B2 (en) *	2004-01-23	2009-06-09	Amgen Inc.	Vanilloid receptor ligands and their use in treatments
DE102004021716A1 (de) *	2004-04-30	2005-12-01	Grünenthal GmbH	Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen
JP4018739B2 (ja) *	2004-07-15	2007-12-05	日本たばこ産業株式会社	縮合ベンズアミド化合物及びバニロイド受容体１型（ｖｒ１）活性阻害剤

2006
- 2006-02-03 FR FR0601007A patent/FR2897061B1/fr not_active Expired - Fee Related
2007
- 2007-01-30 PE PE2007000106A patent/PE20071325A1/es not_active Application Discontinuation
- 2007-01-31 TW TW096103550A patent/TWI401256B/zh not_active IP Right Cessation
- 2007-02-01 DO DO2007000022A patent/DOP2007000022A/es unknown
- 2007-02-01 AT AT07730900T patent/ATE463484T1/de active
- 2007-02-01 DK DK07730900.3T patent/DK1987010T3/da active
- 2007-02-01 NZ NZ569669A patent/NZ569669A/en not_active IP Right Cessation
- 2007-02-01 KR KR1020087019041A patent/KR20080090495A/ko not_active Application Discontinuation
- 2007-02-01 SI SI200730254T patent/SI1987010T1/sl unknown
- 2007-02-01 CN CN2007800042835A patent/CN101379041B/zh not_active Expired - Fee Related
- 2007-02-01 EA EA200870226A patent/EA014450B1/ru not_active IP Right Cessation
- 2007-02-01 CA CA2637333A patent/CA2637333C/fr not_active Expired - Fee Related
- 2007-02-01 RS RSP-2010/0301A patent/RS51366B/en unknown
- 2007-02-01 AU AU2007211399A patent/AU2007211399B2/en not_active Ceased
- 2007-02-01 JO JO200729A patent/JO2602B1/en active
- 2007-02-01 PT PT07730900T patent/PT1987010E/pt unknown
- 2007-02-01 PL PL07730900T patent/PL1987010T3/pl unknown
- 2007-02-01 JP JP2008552848A patent/JP5136938B2/ja not_active Expired - Fee Related
- 2007-02-01 DE DE602007005779T patent/DE602007005779D1/de active Active
- 2007-02-01 BR BRPI0710480-4A patent/BRPI0710480A2/pt not_active IP Right Cessation
- 2007-02-01 EP EP07730900A patent/EP1987010B1/fr active Active
- 2007-02-01 AR ARP070100426A patent/AR059279A1/es not_active Application Discontinuation
- 2007-02-01 WO PCT/FR2007/000183 patent/WO2007088277A1/fr active Application Filing
- 2007-02-01 ES ES07730900T patent/ES2344087T3/es active Active
- 2007-02-01 ZA ZA200806139A patent/ZA200806139B/xx unknown
- 2007-02-02 UY UY30130A patent/UY30130A1/es not_active Application Discontinuation
2008
- 2008-07-06 IL IL192648A patent/IL192648A/en not_active IP Right Cessation
- 2008-08-01 US US12/184,437 patent/US8143248B2/en not_active Expired - Fee Related
- 2008-08-13 NO NO20083520A patent/NO20083520L/no not_active Application Discontinuation
- 2008-08-26 MA MA31193A patent/MA30229B1/fr unknown
2009
- 2009-08-26 HK HK09107854.1A patent/HK1129670A1/xx not_active IP Right Cessation
2010
- 2010-06-07 HR HR20100327T patent/HRP20100327T1/hr unknown
- 2010-07-01 CY CY20101100609T patent/CY1110168T1/el unknown
2012
- 2012-01-24 US US13/357,015 patent/US8288376B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP5136938B2 (ja)	2013-02-06
CN101379041A (zh)	2009-03-04
WO2007088277A1 (fr)	2007-08-09
DOP2007000022A (es)	2007-09-15
EA200870226A1 (ru)	2009-02-27
IL192648A0 (en)	2009-02-11
NZ569669A (en)	2011-05-27
TW200738726A (en)	2007-10-16
IL192648A (en)	2012-06-28
CY1110168T1 (el)	2015-01-14
US20090042873A1 (en)	2009-02-12
CA2637333C (fr)	2015-12-29
AU2007211399B2 (en)	2012-09-20
HRP20100327T1 (hr)	2010-08-31
ZA200806139B (en)	2010-05-26
AU2007211399A1 (en)	2007-08-09
FR2897061B1 (fr)	2010-09-03
US8288376B2 (en)	2012-10-16
US8143248B2 (en)	2012-03-27
PT1987010E (pt)	2010-06-25
SI1987010T1 (sl)	2010-07-30
DE602007005779D1 (de)	2010-05-20
CA2637333A1 (fr)	2007-08-09
BRPI0710480A2 (pt)	2012-08-14
FR2897061A1 (fr)	2007-08-10
ES2344087T3 (es)	2010-08-17
MA30229B1 (fr)	2009-02-02
JO2602B1 (en)	2011-11-01
EP1987010B1 (fr)	2010-04-07
EP1987010A1 (fr)	2008-11-05
NO20083520L (no)	2008-09-11
TWI401256B (zh)	2013-07-11
JP2009525313A (ja)	2009-07-09
PE20071325A1 (es)	2008-02-21
ATE463484T1 (de)	2010-04-15
KR20080090495A (ko)	2008-10-08
CN101379041B (zh)	2012-08-29
EA014450B1 (ru)	2010-12-30
DK1987010T3 (da)	2010-08-02
RS51366B (en)	2011-02-28
AR059279A1 (es)	2008-03-19
US20120122852A1 (en)	2012-05-17
HK1129670A1 (en)	2009-12-04
UY30130A1 (es)	2007-09-28

Publication	Publication Date	Title
IL192648A0 (en)	2009-02-11	Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
IL205759A (en)	2014-07-31	History of isoxazolo-pyridine, a process for their preparation and the drugs containing them
HK1121757A1 (en)	2009-04-30	Pyrroloazacyclic derivatives, preparing method and use thereof
IL182919A0 (en)	2007-09-20	Process for preparing telmisartan and telmisartan derivatives prepared thereby
ZA200810605B (en)	2009-12-30	Substituted pyrazolopyrimidines,a process for their preparation and their use as medicine
HK1117164A1 (en)	2009-01-09	Dicyclic azaalkane derivatives, preparing method and pharmaceutical use thereof
IL193340A0 (en)	2009-05-04	Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL219530A0 (en)	2012-06-28	Substituted 4-aminocyclohexane derivatives and their use for preparing medicaments
PL1973598T3 (pl)	2019-01-31	Aparat do terapii lekowej aktywowanej światłem
SI2069342T1 (sl)	2010-09-30	Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
IL196586A0 (en)	2009-11-18	Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes
IL206394A (en)	2015-10-29	Derivatives of 2-Benzylpyridine Filtration as Met Kinase Inhibitors, Process for their Preparation, Medication and Use
IL204663A0 (en)	2010-11-30	Nicotinamide derivatives, preparastion thereof and therapeutic use thereof
ZA201000185B (en)	2011-03-30	17beta-cyano-18a-homo-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
IL196525A (en)	2015-07-30	A history of spirocyclic azindole, a process for their preparation and medications containing them
HK1159108A1 (en)	2012-07-27	Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
EP2211851A4 (en)	2012-01-04	LAMININS, DERIVATIVES, COMPOSITIONS CONTAINING SAME, AND METHOD FOR THEIR THERAPEUTIC USE
IL208336A (en)	2016-07-31	Pyridazinone derivatives, drugs containing them and their uses and process for preparation
IL194573A0 (en)	2009-09-22	Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof
HK1148228A1 (en)	2011-09-02	Method for preparing optionally substituted p-hydroxymandelic compounds and derivatives thereof
IL190596A0 (en)	2008-11-03	9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
ZA201000187B (en)	2011-03-30	17b-cyano-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
EP2166853A4 (en)	2011-04-06	THERAPEUTIC PYRAZOLONAPHTHYRIDINE DERIVATIVES
HUP0500921A2 (en)	2007-07-30	Tetrazole derivatives, process for their preparation and their use
TWI366566B (en)	2012-06-21	Tricyclic n-heteroarylcarboxamide derivatives, preparation thereof and therapeutic use thereof